Загрузка...
Acute Fatal Liver Toxicity under Erlotinib
We describe the case of a never-smoker who received second-line erlotinib as a treatment for his non-small cell lung cancer. Within one month, acute hepatic failure developed as well as a thrombotic-thrombocytopenic microangiopathy, with fatal outcome. In patients with non-small cell lung cancer, he...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
S. Karger AG
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2919997/ https://ncbi.nlm.nih.gov/pubmed/20740194 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000315366 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|